- Home
- KAR vs TVTX Comparison
KAR vs TVTX Comparison
Compare KAR & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- TVTX
- Stock Information
- Founded
- KAR 2006
- TVTX 2008
- Country
- KAR United States
- TVTX United States
- Employees
- KAR N/A
- TVTX N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- TVTX Health Care
- Exchange
- KAR Nasdaq
- TVTX Nasdaq
- Market Cap
- KAR 2.1B
- TVTX 1.9B
- IPO Year
- KAR 2009
- TVTX N/A
- Fundamental
- Price
- KAR $20.13
- TVTX $17.44
- Analyst Decision
- KAR Buy
- TVTX Strong Buy
- Analyst Count
- KAR 5
- TVTX 13
- Target Price
- KAR $22.20
- TVTX $33.08
- AVG Volume (30 Days)
- KAR 912.0K
- TVTX 1.5M
- Earning Date
- KAR 04-30-2025
- TVTX 05-05-2025
- Dividend Yield
- KAR N/A
- TVTX N/A
- EPS Growth
- KAR N/A
- TVTX N/A
- EPS
- KAR 0.45
- TVTX N/A
- Revenue
- KAR $1,788,500,000.00
- TVTX $233,175,000.00
- Revenue This Year
- KAR $1.43
- TVTX $71.39
- Revenue Next Year
- KAR $6.78
- TVTX $55.24
- P/E Ratio
- KAR $44.22
- TVTX N/A
- Revenue Growth
- KAR 5.47
- TVTX 60.55
- 52 Week Low
- KAR $15.44
- TVTX $5.12
- 52 Week High
- KAR $22.47
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- KAR 46.01
- TVTX 34.91
- Support Level
- KAR $18.87
- TVTX $20.29
- Resistance Level
- KAR $21.42
- TVTX $20.98
- Average True Range (ATR)
- KAR 0.67
- TVTX 1.00
- MACD
- KAR -0.15
- TVTX -0.23
- Stochastic Oscillator
- KAR 49.22
- TVTX 2.01
About KAR OPENLANE Inc.
Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.